Schaffer P, Sancho-Garnier H, Fender M, Dellenbach P, Carbillet J P, Monnet E, Gauthier G P, Garnier A
Programme EVE, Strasbourg, France.
Eur J Cancer. 2000 Nov;36(17):2215-20. doi: 10.1016/s0959-8049(00)00312-9.
In France, as in other European countries the incidence and mortality rates of carcinoma of the cervix uteri indicate a clear decrease in invasive cancers. Opportunistic screening has spread and, presently, approximately 60% of the female population undergo a regular cytological test. This rate increases up to 80% in the younger age groups and decreases to 20% after the age of 60 years. In 1990, intervention procedures were defined at a consensus conference; the major recommendations were to screen all women exclusively by cervical smears, for ages 25-65 years over a 3-year period. Guidelines on the quality control of cervical smear taking and reading were published by the national agency of evaluation of health intervention (ANAES). Since 1990, four population-based, organised pilot programmes, have been implemented in Isère. Doubs, Bas-Rhin and Martinique. These programmes evaluate the participation rate (from approximately 20-80% depending upon the age and the geographical area), the rate of abnormal tests (0.2-3%), according to the laboratories, the cancer detection rate (0.04%-0.15%) and some other quality indicators. Recently (November 1998) a law was passed stipulating that the screening test will be free of charge when performed in agreement with the national recommendations. A specific organisation for cytological quality control will be implemented. An effort to better identify and to include the screening process the women in the population who are not yet participating has to be made.
在法国,与其他欧洲国家一样,子宫颈癌的发病率和死亡率表明浸润性癌症明显减少。机会性筛查已经普及,目前约60%的女性人口定期进行细胞学检查。这一比例在较年轻年龄组中升至80%,在60岁以后降至20%。1990年,在一次共识会议上确定了干预程序;主要建议是在25至65岁的女性中,每3年仅通过宫颈涂片进行筛查。国家卫生干预评估机构(ANAES)发布了宫颈涂片采集和判读质量控制指南。自1990年以来,在伊泽尔、杜省、下莱茵省和马提尼克岛实施了四项基于人群的有组织的试点项目。这些项目评估参与率(根据年龄和地理区域,从约20%至80%不等)、根据实验室情况的异常检查率(0.2%至3%)、癌症检出率(0.04%至0.15%)以及其他一些质量指标。最近(1998年11月)通过了一项法律,规定按照国家建议进行筛查检测将免费。将实施一个专门的细胞学质量控制组织。必须努力更好地识别并将尚未参与筛查过程的女性纳入人群筛查。